Table 1.
Biochemical features of groups studied
| Endotoxin (EU) | Glucose (mmol/L) | Bilirubin (μmol/L) | ALT (UI/L) | AST (UI/L) | |
| Cirrhosis | 0.582 ± 0.069a | 9.41 ± 2.17a | 22.0 ± 6.71ac | 181.2 ± 16.1a | 333.2 ± 84.2a |
| Controls | 0.374 ± 0.037 | 27.63 ± 2.39 | 2.9 ± 0.15 | 68.9 ± 9.9 | 228.3 ± 24.6 |
| Cirrhosis + IGF-1 | 0.432 ± 0.033 | 9.43 ± 0.70a | 10.2 ± 2.96a | 210.3 ± 58.6a | 482.3 ± 121.8a |
| Controls + IGF-1 | 0.363 ± 0.032 | 25.17 ± 2.42 | 3.2 ± 0.10 | 94.4 ± 22.1 | 179.2 ± 30.1 |
| Cirrhosis + R | 0.410 ± 0.041 | 17.75 ± 3.06e | 5.0 ± 1.23 | 121.4 ± 18.4 | 262.1 ± 49.1 |
| Controls + R | 0.368 ± 0.027 | 29.39 ± 2.08 | 3.1 ± 0.20 | 97.7 ± 23.4 | 236.2 ± 43.2 |
P < 0.05 vs all control groups;
P < 0.05 vs cirrhosis + R;
P < 0.05 vs control + R. IGF: Insulin-like growth factor; R: Rifaximin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.